Popular Articles
Natural Remedies

Rhode Island Dept. Of Health Applauds New Tobacco Law, USA
The Rhode Island Department of Health (HEALTH) recognizes and applauds the significant public health achievement of The Family Smoking Prevention and Tobacco Control Act being signed into law. This new law gives the U.S. Food and Drug Administration (FDA) the authority to regulate tobacco products.
generic viagra online
Massachusetts Cuts Health Coverage By $115 Million
"Overseers of Massachusetts" trailblazing health care program made their first cuts recently, trimming $115 million, or 12 percent, from Commonwealth Care, which subsidizes premiums for needy residents and is the centerpiece of the 2006 law," according to the Boston Globe. The Connector Authority board made the cuts in response to two recession side effects: "the state budget crisis and a surge in enrollment by the recently unemployed." Commonwealth Care"s enrollment has increased in the last three months from 165,000 member to 177,000 members, and is projected to grow to 212,000 next year.
News of the day
Celera Presents Data Replicating Its Immunodiagnostic Assay To Detect Lung Cancer From Blood Serum
Celera Corporation (NASDAQ:CRA) announced yesterday the presentation of data replicating its novel mass spectrometry-based approach to identify and validate circulating protein biomarkers that detect non-small cell lung cancer (NSCLC) in an independent cohort of individuals with lung cancer. This study was performed in collaboration with scientists at NYU Langone Medical Center, NY. A key outcome of the study was the validation of a 9 biomarker immunoassay on a cohort of samples that is enriched for stage I disease, important for screening of early stage disease. The assay detected lung cancer with 92% sensitivity at 93% specificity. The panel also accurately distinguished malignant cases from benign lung disease. The data is being presented at the 13th World Conference on Lung Cancer as part of the International Association for the Study of Lung Cancer (IASLC) in San Francisco, CA.
Medical Devices

Impact Of Medicare Part D On Medical Spending Addressed By NEJM Study

After enrolling in Medicare Part D, seniors who previously had limited or no drug coverage spent more on prescriptions and less on other medical care services such as hospitalizations and visits to the doctor"s office, according to a University of Pittsburgh Graduate School of Public Health study. Published in the July 2 issue of the New England Journal of Medicine, the study also found that seniors who had relatively good drug benefits prior to enrolling in Medicare Part D spent somewhat more on prescriptions and, at the same time, increased their spending on other medical care services. "We found that Part D led to increases in overall pharmacy spending among all beneficiaries," said the study"s lead author, Yuting Zhang, Ph.D., assistant professor of health economics at the University of Pittsburgh Graduate School of Public Health. "These increases were offset by decreases in spending on other medical care services in those with little or no drug coverage before they enrolled in Medicare Part D, which was one-third of the beneficiary population studied. The majority of Part D enrollees in our study population - those with relatively good prior prescription coverage - spent more on prescriptions as well as other medical services." The purpose of Medicare Part D, which took effect in January 2006, is to subsidize the cost of prescription drugs for Medicare beneficiaries, more than 30 percent of whom had limited or no coverage for prescription drugs prior to its implementation. Dr. Zhang and her colleagues compared prescription drug use and other medical spending among three groups of senior citizens two years before and after Part D was implemented. The groups included beneficiaries with no prior drug coverage, poor prior drug coverage ($600 maximum per year) and relatively good prior drug coverage ($1,400 maximum per year, comparable to Part D). They found that total monthly prescription drug spending increased by 74 percent among the no-coverage group; by 27 percent among the poor-coverage group; and by 11 percent among the good-coverage group. The study also found that the use of both lipid-lowering and anti-diabetic medications rose in the groups with limited or no drug coverage. When it came to spending on other medical care services excluding drugs, the no-coverage group and poor-coverage group decreased their spending by $33 and $46 per month respectively, while the good-coverage group increased their spending by $30 per month. "The offset in spending by seniors with limited or no prior drug benefits could be due to improved adherence to medication, especially for those with chronic conditions. Improved access to prescription drugs provided by Part D may enable this population to better control symptoms and cut down on visits to the physician"s office or emergency room," said Dr. Zhang. On the other hand, the lack of a similar spending offset in the good-coverage group could indicate an overuse of some medications and services by this population, she noted. Co-authors of the study include senior author Joseph P. Newhouse, Ph.D., Harvard University; Julie M. Donohue, Ph.D., and Judith R. Lave, Ph.D., University of Pittsburgh Graduate School of Public Health; and Gerald O"Donnell, M.S., Highmark Inc., Pittsburgh. The study was funded in part by a grant to Dr. Donohue from the National Institutes of Health and a grant to Dr. Newhouse from the Alfred P. Sloan Foundation. Clare Collins University of Pittsburgh Schools of the Health Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):